KPC mice were monitored until tumor detection by ultrasound and treated using anti-CD73 (clone 2C5) antibody or isotype control for 3 weeks (short-treatment cohort) or until clinical end points were met (long-treatment cohort; see Materials and Methods; Fig. 6D). Here, NT5E is linked to neoplasm.